Skip Navigation
Skip to contents

IMKASID2022

Region-Specific Forum: May 13 (Fri), 08:30~10:00, Room A

  • Choosing and Positioning Biologic Therapy for Biologic-Naïve IBD Patients Julajak Limsrivilai Mahidol University
    Thailand
    CV
  • Implementing Quality Measures for IBD Patients Wong Zhiqin The National University of Malaysia
    Malaysia
    CV
  • Infectious Mimics of IBD Dao Viet Hang Hanoi Medical University
    Vietnam
    CV
  • The Many Faces of Cytomegalovirus in IBD Rabbinu Rangga Pribadi Cipto Mangunkusumo National General Hospital
    Indonesia
    CV
  • Diagnosing and Managing C. Difficile Infection in IBD Thien Myint Grand Hantha International Hospital
    Myanmar
    CV

KASID-MISGKAI Joint Symposium: May 13 (Fri), 08:30~10:00, Room B

  • Macrophages in Intestinal Inflammation and Resolution Seung Hyeok Seok Seoul National University
    Korea
    CV
  • Regulation of Gut-Homing T Cells in Inflammatory Bowel Disease Seong-Joon Koh Seoul National University
    Korea
    CV
  • Current Strategies and Potential Prospects of Nanomedicine-mediated Therapy Yonghyun Lee Ewha Womans University
    Korea
    CV
  • Dietary Fiber and Inflammatory Bowel Disease Sung Wook Hwang University of Ulsan
    Korea
    CV

Symposium 1: May 13 (Fri), 10:20~11:50, Room A The Cutting-edge Issues in IBD

  • Can We Predict the Development of IBD using a Multi-Omics Approach? Jean-Frederic COLOMBEL Icahn School of Medicine at Mount Sinai
    USA
    CV
  • The Long Journey to Prevent and Overcome the Development of Fibrosis and Stricture in IBD Florian Rieder Cleveland Clinic
    USA
    CV
  • Proper Positioning of Biologics and Small Molecules in Patients with IBD Silvio Danese University Vita-Salute San Raffaele
    Italy
    CV
  • Exit Strategies: Can We Stop Medications in Patients with IBD? Kang-Moon Lee The Catholic University of Korea
    Korea
    CV

Symposium 2: May 13 (Fri), 10:20~11:50, Room B Hot Topics in Epidemiology, Screening, and Prevention of Colorectal Cancer

  • Colorectal Cancer Screening: Tests, Strategies, and Perspectives Hyun-Soo Kim Yonsei University
    Korea
    CV
  • Prevention of Colorectal Cancer: Foods, Exercise, and Lifestyle Modifications, Do They Really Work?  Aesun Shin Seoul National University
    Korea
    CV
  • Chemoprevention of Colorectal Cancer: How to Apply It in Clinical Practice? Jianguang Ji Lund University
    Sweden
    CV
  • KASID-GEST Joint Symposium: May 13 (Fri), 10:20~11:50, Room C Microbiome in Colorectal Neoplasia

    • Who is the Foe?: Gut Microbiome and Colorectal Neoplasm Soo-Young Na The Catholic University of Korea
      Korea
      CV
    • Microbiota-Associated Mechanisms in Colorectal Carcinogenesis Chun-Ying Wu National Yang Ming Chiao Tung University
      Taiwan
      CV
    • Are We Ready for Microbiota-Based Screening of Colorectal Cancer? Hong Sub Lee Inje University
      Korea
      CV
    • Our Old Friend, Probiotics for Prevention of Colorectal Neoplasia Chi-Yang Chang Fu Jen Catholic University Hospital
      Taiwan
      CV
    • Luncheon Symposium 1 : May 13 (Fri), 11:50~12:40, Room A

      • Disease Clearance as a Treatment Goal in Ulcerative Colitis:
        From Concept to Clinical Practice
        Silvio Danese University Vita-Salute San Raffaele
        Italy
        CV
      • Targeting Progression
        of Crohn’s Disease to Improve
        Patient Outcomes
        Young-Ho Kim Sungkyunkwan University
        Korea
        CV
      • Luncheon Symposium 1 May 13 (Fri), 11:50~12:40, Room B Daewoong Pharmaceutical Co., Ltd.

        • Optimal Dose of Mesalazine in Ulcerative Colitis:
          Focused on High Dose Mesalazine
          Johan Burisch University of Copenhagen
          Denmark
          CV
        • An Innovative Colonic Targeting:
          OPTICORE Coating Technology
          Jae Hee Cheon Yonsei University
          Korea
          CV
        • Luncheon Symposium 2 : May 13 (Fri), 12:40~13:30, Room A

          • Up-to-Date Evidence and Experience on
            CD: Including the First Head-to-Head
            Results and Asian Experience
            Takayuki Matsumoto Iwate Medical University
            Japan
            CV
          • Recent Clinical Data and Guidelines
            to Support Evidence-Based Decisions in UC
            Byong Duk Ye University of Ulsan
            Korea
            CV
          • Luncheon Symposium 2 : May 13 (Fri), 12:40~13:30, Room B

            • Safety and Efficacy of the 1st Adalimumab Biosimilar in IBD Treatment based on
              Real World Evidence
              Milan Lukas Charles University
              Czech
              CV
            • IBD Treatment Journey with the 1st
              Adalimumab Biosimilar
              Chang-Kyun Lee Kyung Hee University
              Korea
              CV
            • Symposium 3: May 13 (Fri), 14:10~15:40, Room A Recent Advances in High Quality Colonoscopy & Surveillance of Colorectal Cancer

              • High-Quality Screening Colonoscopy: A Matter of Time, Technique, or Technology? David G. Hewett The University of Queensland
                Australia
                CV
              • Distinguishing between Different Bowel Preparation Agents:
                How to Make the Right Choice?
                Jae Myung Cha Kyung Hee University
                Korea
                CV
              • Update on Post-Polypectomy Surveillance Guidelines: What has Changed? Min Seob Kwak Kyung Hee University
                Korea
                CV

              Symposium 4: May 13 (Fri), 14:10~15:40, Room B Up-to-date Research in Gut Microbiome

              • Intestinal Organoids as a Novel Model for Host-Microbiome Interaction Toshiro Sato Keio University
                Japan
                CV
              • COVID-19 and Human Gut Microbiome: What Do We Know? Siew C. Ng The Chinese University of Hong Kong
                China
                CV
              • Gut Microbiome as a Novel Biomarker in IBD Dong Il Park Sungkyunkwan University
                Korea
                CV

              Symposium 6: May 13 (Fri), 16:00~17:30, Room B Deep Dive into Small Bowel Diseases

              • Drug-induced Small Bowel Injury: A Time to Take Care Seong-Eun Kim Ewha Womans University
                Korea
                CV
              • CEAS and CMUSE: Who are you? Takayuki Matsumoto Iwate Medical University
                Japan
                CV
              • Role of Endoscopy for Small Bowel Tumors Jinsu Kim The Catholic University of Korea
                Korea
                CV
              • Advances in Therapeutic Endoscopy for Small Bowel Disease Chia-Hung Tu National Taiwan University
                Taiwan
                CV
Hosted by
Supported by

상단으로 이동

Korean Association for the Study of Intestinal Diseases
31, Seolleung-ro 86-gil, Gangnam-gu, Seoul, 06193, Korea
Tel. +82-2-957-6145 l Fax. +82-2-957-6146 l E-mail: thekasid2@gmail.com
IMKASID 2022 Secretariat
Tel. +82-2-6411-7380, 7311  |  Fax. +82-2-6411-7399  
E-mail: imkasid@innon.co.kr